Additional Ebola Cases Recorded In DRC; U.S. Investments Critical To Stop Outbreak, Prevent Spread, Experts Testify During Senate Subcommittee Hearing

CIDRAP News: Eight more sickened in DRC’s Ebola outbreak
“An uptick in the rate of newly confirmed Ebola cases in the Democratic Republic of Congo’s outbreak continued [Tuesday], with the country’s health ministry reporting eight illnesses in four locations. In other outbreak developments, the World Health Organization (WHO) African regional office in a weekly report [Tuesday] noted two more infections in health workers, and though Katwa is still the hot spot, seven health zones that have reported recent cases are points of concern…” (Schnirring, 3/19).

Homeland Preparedness News: Senate hearing highlights value of Ebola investments White House proposal would cut
“The ongoing Ebola outbreak in the Democratic Republic of Congo was the topic of a hearing before the Senate Appropriations Labor, Health and Human Services Subcommittee…, highlighting successes and failures in the fight against it. … Experts testified that U.S. investments in biomedical research and global health security have led to a vaccine administered to more than 87,000 people. It has also contributed to increased surveillance and preparedness efforts in neighboring nations, greatly reducing the risk of a pandemic — all things at risk if a White House budget proposal for 2020 passes…” (Galford, 3/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.